Components of Polio Vaccine	Excipients Table Allergens Table Components Table
Indication Immunization against polio-virus types 1, 2, and 3 Proprietary Name IPOL Manufacturers sanofi pasteur Viability Inactivated Approved Ages 6 weeks of age and older Dose 0.5 mL Route Intramuscular or subcutaneous Dose form Suspension Appearance Clear and Colorless Concentration (per 0.5 mL) Type 1 Poliovirus, 40 D antigen units Type 2 Poliovirus, 8 D antigen units Type 3 Poliovirus, 32 D antigen units Excipients Newborn calf serum from bovine spongiform encephalopathy free countries, <1 ppm Adjuvants None Allergens Neomycin,<5 ng Streptomycin, 200 ng Polymyxin, 25 ng Dry natural latex rubber Preservatives 2-phenoxyethanol, 0.5% Formaldehyde, ≤ 0.02% Media Vero cells from monkey kidney cells of Vervet or African green monkeys. Grown in Eagle MEM modified medium. For viral growth the culture medium is replaced by M-199 without calf serum. Packaging Single dose syringe (without needle) 10-dose vial Routine storage 2 to 8° C (35-46° F) Do not freeze Package Insert Date December 2005 updated January 2012
This page was last updated on January 24, 2012 © 2012 Institute for Vaccine Safety